David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay, Head of the Thoracic Group and CICT at the Department of Medical Oncology, shared a post on LinkedIn:
“It’s a pleasure to hear Profs Rolf Stahel and Triparna sen talk about resistance to targeted therapies in the lung (particularly EGFR) from a clinical and translational research angle.”
